Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty, Randomized, Controlled Trial: iTrack (Nova Eye Medical) Compared to Omni (Sight Sciences)

NCT04769453 is registered in ClinicalTrials.gov with Nova Eye, Inc. as lead sponsor.

NCT NCT04769453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04769453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty, Randomized, Controlled Trial: iTrack (Nova Eye Medical) Compared to Omni (Sight Sciences)
Lead sponsor
Nova Eye, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
April 29, 2021
Completion date
January 26, 2023
Enrollment
20 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma